EVEREST ORGANICS share price has zoomed 7% and is presently trading at Rs 149.5.
Meanwhile, the BSE HEALTHCARE index is at 44,174.7 (up 0.8%).
Among the top gainers in the BSE HEALTHCARE index today are FORTIS HEALTHCARE (up 2.5%) and Procter & Gamble Health (up 2.4%).
SYNGENE INTERNATIONAL (down 1.2%) and ERIS LIFESCIENCES (down 1.0%) are among the top losers today.
Over the last one year, EVEREST ORGANICS has moved up from Rs 125.9 to Rs 149.5, registering a gain of Rs 23.6 (up 18.7%).
On the other hand, the BSE HEALTHCARE index has moved up from 28,436.8 to 44,174.7, registering a gain of 55.3% during the last 12 months.
The top gainers among the BSE HEALTHCARE index stocks during this same period were SUVEN PHARMACEUTICALS (up 134.5%), Jubilant Pharmova (up 129.2%) and GRANULES INDIA (up 121.6%).
Must See: These Segments are Witnessing Incredible Growth with Modi's Push
The BSE Sensex is at 81,978.9 (up 0.1%).
The top gainers among the BSE Sensex today are Asian Paints (up 0.8%) and Bajaj Finance (up 0.8%). The most traded stocks in the BSE Sensex are Tata Motors and Tata Steel.
In the meantime, NSE Nifty is at 25,045.8 . Bajaj Auto and Dr. Reddys are among the top gainers in NSE NIFTY.
Over the last 12 months, the BSE Sensex has moved up from 67,127.1 to 81,978.9, registering a gain of 14,851.9 points (up 22.1%).
EVEREST ORGANICS net profit fell 18008.8% YoY to Rs -61 million for the quarter ended June 2024, compared to a profit of Rs 0 million a year ago. Net sales declined 24.0% to Rs 324 million during the period as against Rs 427 million in April-June 2023.
For the year ended March 2023, EVEREST ORGANICS reported 115.9% decrease in net profit to Rs -2 million compared to net profit of Rs 11 million during FY22. Revenue of the company fell 7.4% to Rs 1,574 million during FY23.
The current Price to earnings ratio of EVEREST ORGANICS, based on rolling 12 month earnings, stands at -20.0.
Equitymaster requests your view! Post a comment on "EVEREST ORGANICS Gains 7%; BSE HEALTHCARE Index Up 0.8%". Click here!
Comments are moderated by Equitymaster, in accordance with the Terms of Use, and may not appear
on this article until they have been reviewed and deemed appropriate for posting.
In the meantime, you may want to share this article with your friends!